Validation of a Score Developed to Estimate the 6-month Survival of Patients Treated with Palliative Local Radiotherapy for Advanced Lung Cancer.
To validate a score estimating the 6-month survival of lung cancer patients irradiated for locally advanced disease. The validation cohort of this study included 125 patients. The score for each patient was calculated by adding the points (6-month survival divided by 10) from the factors lymph node stage, distant metastasis and performance score. Patients were divided into three groups, 10-11 (N=36), 12-14 (N=69) and 15-17 points (N=20). Six-month survival of each group from the original study was compared to its corresponding group from this validation study. Six-month survival rates were 19% (10-11 points), 51% (12-14 points) and 75% (16-17 points) in the validation cohort (p<0.001) and 13%, 47% and 82% in the previous study (p<0.001). The group-by-group comparisons between both cohorts did not reveal any significant differences. The score was reproducible and valid for estimating the 6-month survival of lung cancer patients assigned to palliative thoracic radiotherapy.